The expanding demand for controlled immunological investigation and therapeutic design has spurred significant improvements in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently produced using diverse expression platforms, including bacterial hosts, higher cell lines, and baculovi